China Medical System (00867 HK) MSCI-ESG Rating Upgraded to AA, Reaching Global Level – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Tuesday, 22 December 2020, 4:02 pm
Morgan Stanley Capital International (MSCI) issued a
report on December 17 upgrading the ESG (Environmental,
Social and Governance) Rating for China Medical System
Holdings Limited ( China Medical System ), a
well-established, innovation-driven specialty pharma with a
focus on sales & marketing in China. China Medical
System s ESG Rating has been upgraded from BBB to AA ,
surpassing 88% of companies in the global pharmaceutical
industry, symbolizing that the Company has attained a level
among its global peers in ESG management.
MSCI
recognized China Medical System s outstanding performance in
Corporate Governance, Corporate Behavior, Product Safety and
Quality, Human Capital Development, and Access to Health
-3.15
As of October 31, 2020, the Fund s market price and NAV per share were $10.49 and $12.66, respectively, reflecting a discount of 17.14%, compared with a discount of 12.63% at the end of fiscal year 2019.
During fiscal year 2020, the Fund and Impulsora had in place an Expense Limitation Agreement, in which the Fund s ordinary annual expense ratio was limited to 1.50% through October 31, 2020, as long as Fund net assets remained greater than $200 million. The agreement was reinforced for fiscal year 2021, as the Fund announced on November 3, 2020, a further reduction in some expenses. In addition, the commitment to limit the ordinary expense ratio at 1.50% was maintained for fiscal year 2021, but with a lower threshold for Fund net assets of $180 million, instead of the prior threshold of $200 million.
China Medical System (00867.HK) MSCI-ESG Rating Upgraded to AA , Reaching a Leading Global Level
BriefingWire.com, 12/21/2020 - On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Environmental, Social and Governance) rating for China Medical System Holdings Limited ( China Medical System ), a well-established, innovation-driven specialty pharma with a focus on sales & marketing in China. According to the report, China Medical System s ESG rating has been upgraded from BBB to AA , surpassing 88% of companies in the global pharmaceutical industry, and symbolizing that the Company has reached a leading level among its global peers in ESG management.
Climate change policies mean ESG companies will continue to perform It s clear that with climate change policy, ESG companies are likely to continue performing favourably. Peter McGahan Related stories
LAST week we talked about ESG and its impact on society and your money.
Environment, Social and Governance (ESG) are the three pillars responsible businesses are aspiring to, under which they are moving towards a fairer society, which takes care of the Earth - our home, in the process.
There are many benefits to ESG policies, one of which is a dampener on consumerism and its impact on happiness.
By the time I order my iPhone 12, the iPhone 15 will already be designed, ripping unnecessary natural resources from the ground, unnecessary money from your bank account, and creating significant unhappiness for those who ‘need’ the next best thing, let alone toxic landfill.